|
Pharmacological Group: Antivirals, Active Principle: Aciclovir Sodico, Pharmaceutical Form: Injectable Po, Concentration / Dosage: 250, Unit: Mg, Volume: Not Applicable, Presentation: Vial, Accessory: Not Applicable, Active Principle: Aciclovir, Form Pharmaceutical: Compressed, Concentration / Dosage: 200, Presentation: Not Applicable, Pharmacological Group: Antibacterials, Active Principle: Amicacin Sulfate, Pharmaceutical Form: Injectable Solution, Unit: Mg / Ml, Volume: 2Ml, Presentation: Ampla, Active Principle: Triidrate Amoxicillin 61Mg / Ml, Pharmaceutical Form: Oral Suspension, Concentration / Dosage: 50, Unit: Mgml, Volume: 150Ml (After Reconstitution), Presentation: Bottle, Active Principle: Amoxicillin+Clavulanic Acid, Concentration / Dosage: 1000+200 , 04/02/2025, 02/17/2025, Active Principle: Amoxicillin + Potassium Clavulanate, Pharmaceutical Form: Po For Oral Suspension, Concentration/Dosage: 50 + 12, 5, Volume: 75 To 100Ml After Reconstitution, Accessory: N / A, Pharmaceutical Form: Coated Tablet, Concentration / Dosage: 500+125, Active Principle: Ampicillin Sodica, Pharmaceutical Form: Po For Injectable Solution, Concentration / Dosage: 500, Volume: N / A, Pharmacological Group: Antifungal, Principle Active: Lipido Amphotericin B-Complex, Pharmaceutical Form: Injectable Suspension, Concentration / Dosage: 5, Volume: 20 Ml, Form Supply: Unit, Active Principle: Amphotericin B Liposomal, Active Principle: Azithromycin, Concentration / Dosage: 40, Volume: 15Ml (After Reconstitution), Active Principle: Benzilpenesicillin Benzatin, Concentration / Dosage: 1.200.000, Unit: Ui, Concentration / Dosage: 600.000, Active Principle: Benzilpeneicillin Potassic, Pharmaceutical Form: Polyofilo Injectable (Crystalline), Concentration / Dosage: 5,000,000, Active Principle: Cephalexin, Volume: 60Ml After Reconstitution, Pharmaceutical Form: Capsule/Compressed, Presentation: N/A, Pharmacological Group: Antibiotic, Active Principle: Cephazolina Sodica, Concentration/Dosage: 1, Unit: G, Principle Active: Cefepima, Active Principle: Ceftazidima, Active Principle: Ceptriaxone, Pharmaceutical Form: Injectable Pope (Intravenous And Intramuscular Route), Active Principle: Cefuroxima Sodic, Concentration / Dosage: 750, Active Principle: Cefuroxima, Active Principle: Axethyl Cefuroxima, Volume: 50, Active Principle: Ciprofloxacin Hydrochloride, Concentration / Dosage: 2, Volume: 100Ml, Presentation: Bag, Active Principle: Monohydrate Hydrochloride Ciprofloxacin, Active Principle: Claritromycin, Concentration / Dosage: 250/5, Volume: 50 A 60Ml (After Reconstitution), Presentation: Ml, Active Principle: Clindamycin Phosphate, Concentration / Dosage: 150, Volume: 4Ml, Active Principle: Clindamycin Hydrochloride, Pharmaceutical Form: Capsule, Concentration / Dosage: 300, Pharmacological Group: Antibiotic, Active Principle: Pentaidrated Ceptazidima + Avibactam Sodico, Pharmaceutical Form: Injectable, Concentration / Dosage: 2000 + 500, Unit: Mg + Mg, Volume: Na, Presentation: Bottle / Ampolo, Active Principle: Ceptolozana + Tazobactam, Concentration / Dosage: 1000+500, Unit: Mg+Mg
|
